Abstract |
|
Authors | Ian R Hardcastle, Shafiq U Ahmed, Helen Atkins, A Hilary Calvert, Nicola J Curtin, Gillian Farnie, Bernard T Golding, Roger J Griffin, Sabrina Guyenne, Claire Hutton, Per Källblad, Stuart J Kemp, Martin S Kitching, David R Newell, Stefano Norbedo, Julian S Northen, Rebecca J Reid, K Saravanan, Henriëtte M G Willems, John Lunec |
Journal | Bioorganic & medicinal chemistry letters
(Bioorg Med Chem Lett)
Vol. 15
Issue 5
Pg. 1515-20
(Mar 01 2005)
ISSN: 0960-894X [Print] England |
PMID | 15713419
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 3-(4-chlorophenyl)-3-(4-hydroxy-3,5-dimethoxybenzyloxy)-2-propyl-2,3-dihydroisoindol-1-one
- Indoles
- Nuclear Proteins
- Proto-Oncogene Proteins
- Tumor Suppressor Protein p53
- MDM2 protein, human
- Proto-Oncogene Proteins c-mdm2
|
Topics |
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Humans
- Indoles
(chemical synthesis, chemistry, pharmacology)
- Models, Molecular
- Molecular Structure
- Nuclear Proteins
(chemistry, drug effects, metabolism)
- Protein Binding
(drug effects)
- Proto-Oncogene Proteins
(chemistry, drug effects, metabolism)
- Proto-Oncogene Proteins c-mdm2
- Structure-Activity Relationship
- Transcription, Genetic
(drug effects)
- Tumor Suppressor Protein p53
(chemistry, drug effects, genetics, metabolism)
|